Biotech · Private company
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Track this companyFree. Adds Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MORF-057Phase 2 · Inflammatory Bowel DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- MORF-057Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseasePHASE2 · RECRUITING · started Jul 18, 2024ClinicalTrials.gov NCT06226883 · fetched Nov 12, 2026
- A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UCPHASE2 · COMPLETED · started Nov 21, 2022ClinicalTrials.gov NCT05611671 · fetched Nov 12, 2026
- A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UCPHASE2 · COMPLETED · started Apr 13, 2022ClinicalTrials.gov NCT05291689 · fetched Nov 12, 2026
- Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy VolunteersPHASE1 · COMPLETED · started Sep 23, 2020ClinicalTrials.gov NCT04580745 · fetched Nov 12, 2026